Naloxone
Formulations: - Parenteral > General injections > unspecified: 400 µg per 1 mL in ampoule (naloxone hydrochloride) Indications: - Unintentional exposure to or harmful effects of opioids or related analgesics Source: EML workbook import

Browse procurement-ready healthcare products from trusted vendors across the Afya Chain marketplace.
Formulations: - Parenteral > General injections > unspecified: 400 µg per 1 mL in ampoule (naloxone hydrochloride) Indications: - Unintentional exposure to or harmful effects of opioids or related analgesics Source: EML workbook import
Formulations: - Oral > Solid: 250 mg Indications: - Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified - Rheumatoid arthritis, serology unspecified Source: EML workbook import
Formulations: - Oral > Solid: Powder for oral administration Indications: - Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 200 mg per mL in 5 mL ampoule Indications: - Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 30 mg per mL in 10 mL ampoule Indications: - Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 250 mg per mL in 50 mL ampoule - Local > Topical > Solution: 15% Indications: - Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified - Pityriasis versicolor Source: EML workbook import
Formulations: - Oral > Solid: 100 mg Indications: - Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified Source: EML workbook import
Formulations: - Oral > Liquid: 125 mg powder for oral suspension (in sachet) Oral > Solid > capsule: 80 mg; 125 mg; 165 mg Indications: - Nausea or vomiting Source: EML workbook import
Indications: - Nausea or vomiting - Palliative care Source: EML workbook import
Triazole antifungal for candidiasis and cryptococcal infections
Ready to amplify your rewards? Drop your email and we'll be in touch soon.